"A single product in a big class of products with the same chemical isn't going to make a dent in oxycodone use," Walsh said.
Well maybe we need to start with one...SequestOx
"I'd be open to seeing an efficacy trial in this specific chronic pain population," Passik said
Well this is an immediate release opiate is that study going to happen unless its for breakthrough pain??
But, good to see the FDA is showing some consistency in this madness. I had no idea there were this many me too opiates in the pipeline. Must mean there is money in it. lol